Sullivan Eddie Joe 13D and 13G filings for SAB Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-08 5:07 pm Purchase |
2022-09-07 | 13D | SAB Biotherapeutics, Inc. SABS |
Sullivan Eddie Joe | 571,911 13.300% |
1,400 (+0.25%) |
Filing |
| 2021-11-01 4:55 pm Purchase |
2021-10-22 | 13D | SAB Biotherapeutics, Inc. SABS |
Sullivan Eddie Joe | 570,511 13.120% |
570,511 (New Position) |
Filing |